-
This report describes a large group of patients with hypertrophic cardiomyopathy (HCM) who underwent implantable cardioverter defibrillator (ICD) implantation at 42 referral and nonreferral institutions in the United States, Europe and Australia.
-
Aliskiren is a new class of drugs that directly inhibit renin and is approved in the U.S.A. for the treatment of hypertension. Valsartan is the best selling antihypertensive medication in the world.
-
Coronary deaths in the united states have dramatically declined since 1968. A new report consists of an analysis of mortality trends for coronary heart disease (CHD) mortality in the United States between 1980 and 2000, among U.S. adults 25 to 84 years of age.
-
Lee and co-workers examined the effects of associated cardiac and noncardiac conditions on survival in ICD recipients.
-
Most cases of acute pericarditis are due to idiopathic or viral causes and have a benign prognosis with symptomatic treatment. How to identify those cases due to specifically treatable causes or those who are not going to do well would be useful to know.
-
Left ventricular (LV) diastolic dysfunction is believed to be an important mechanism of heart failure in patients with hypertension. However, there are currently no specific treatments for diastolic dysfunction.
-
-
SSRIs are associated with a low rate of birth defects according to 2 new studies in the New England Journal of Medicine. SSRIs are often taken by women in their childbearing years, but the risk of birth defects has been unclear.
-
Despite encouraging animal studies and human observational studies such as the Nurses Health Study, prospective randomized placebo-controlled trials such as the Women's Health Initiative (WHI) ...
-
In this paper, hart, pearce and aguilar report the results of a meta-analysis of antithrombotic therapy in patients with nonvalvular atrial fibrillation (NVAF).